中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
26期
166-167
,共2页
慢性胃炎%奥美拉唑%克拉霉素%疗效%不良反应
慢性胃炎%奧美拉唑%剋拉黴素%療效%不良反應
만성위염%오미랍서%극랍매소%료효%불량반응
Chronic gastritis%Omeprazole%Clarithromycin%Efficacy%Adverse reaction
目的：探讨慢性胃炎患者采用奥美拉唑及克拉霉素联合治疗的临床疗效及安全性分析。方法选取我院收治的120例慢性胃炎患者，随机分为观察组和对照组，每组60例，观察组采用奥美拉唑及克拉霉素联合治疗，对照组仅采用奥美拉唑进行治疗。结果观察组的总有效率高于对照组患者，χ2=6.9878，P＜0.01，差异具有统计学意义；两组均肝、肾功能治疗前后无显著变化，均无严重不良反应发生。结论奥美拉唑及克拉霉素联合慢性胃炎患者的临床疗效优于单用奥美拉唑，且不良反应轻微，有助于加快患者的康复及提高生活质量。
目的：探討慢性胃炎患者採用奧美拉唑及剋拉黴素聯閤治療的臨床療效及安全性分析。方法選取我院收治的120例慢性胃炎患者，隨機分為觀察組和對照組，每組60例，觀察組採用奧美拉唑及剋拉黴素聯閤治療，對照組僅採用奧美拉唑進行治療。結果觀察組的總有效率高于對照組患者，χ2=6.9878，P＜0.01，差異具有統計學意義；兩組均肝、腎功能治療前後無顯著變化，均無嚴重不良反應髮生。結論奧美拉唑及剋拉黴素聯閤慢性胃炎患者的臨床療效優于單用奧美拉唑，且不良反應輕微，有助于加快患者的康複及提高生活質量。
목적：탐토만성위염환자채용오미랍서급극랍매소연합치료적림상료효급안전성분석。방법선취아원수치적120례만성위염환자，수궤분위관찰조화대조조，매조60례，관찰조채용오미랍서급극랍매소연합치료，대조조부채용오미랍서진행치료。결과관찰조적총유효솔고우대조조환자，χ2=6.9878，P＜0.01，차이구유통계학의의；량조균간、신공능치료전후무현저변화，균무엄중불량반응발생。결론오미랍서급극랍매소연합만성위염환자적림상료효우우단용오미랍서，차불량반응경미，유조우가쾌환자적강복급제고생활질량。
Objective To explore the clinical efficacy and safety of omeprazole and clarithromycin combine treatment in patients with chronic gastritis.Methods Selected 120 patients with chronic gastritis in our hospital were randomly divided into observation group and control group, each group had 60 cases. The former uses omeprazole and clarithromycin, the latter only with omeprazole treatment.ResultsThe observation group total efficiency was higher than the control group, χ2=6.987 8,P<0.01, had difference statistically significance. Two groups were liver and renal function before and after treatment no significant change, and had no serious adverse reactions. Conclusion The clinical efifcacy of omeprazole and clarithromycin combined with chronic gastritis patients is better than single use of omeprazole and adverse reaction of slightly, can help to speed up the rehabilitation of patients and improve the patient's quality of life.
